StonvexLoading…
StonvexStonvexStonvexCore line items from NBBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $105.69M | $335.75M | $238.39M | $156.70M |
Operating Income | $20.35M | $71.13M | $56.25M | $36.29M |
Net Income | $14.98M | $50.30M | $42.60M | $27.23M |
EPS (Diluted) | $0.36 | $1.34 | $1.14 | $0.72 |
Total Assets | $7.23B | $7.01B | $5.44B | $5.23B |
Total Liabilities | $6.38B | $6.15B | $4.71B | $4.49B |
Cash & Equivalents | $375.36M | $407.60M | $295.38M | $258.70M |
Free Cash Flow OCF − CapEx | $25.30M | $57.38M | $59.87M | $35.93M |
Shares Outstanding | 44.77M | 45.77M | 39.83M | 40.75M |